JESSICA HENDERSON: Open Payments
NPI 1588204077 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 76 payments from 19 companies in 2025. Trend: 2023 $26 · 2024 $170 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 32 | $245 |
| ABBVIE INC. | 17 | $200 |
| Grifols USA, LLC | 3 | $97 |
| Janssen Biotech, Inc. | 3 | $83 |
| Biogen, Inc. | 3 | $81 |
| Genentech USA, Inc. | 3 | $54 |
| EMD Serono, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: ZEPOSIA, QULIPTA, Gamunex-C, Ocrevus Zunovo, TYSABRI, BOTOX, AMYVID, ULTOMIRIS.
Industry payments across TX — which companies pay providers there.
